Find clinical trials for Non-Small-Cell Lung Cancer in Portland, OR
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near Portland, OR, USA:
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Portland, Oregon, United States and 48 other locations
with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...
Phase 2
Portland, Oregon, United States and 60 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Portland, Oregon, United States and 123 other locations
This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...
Phase 2
Portland, Oregon, United States and 157 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Salem, Oregon, United States and 238 other locations
combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...
Phase 1
Portland, Oregon, United States and 72 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Portland, Oregon, United States and 252 other locations
alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...
Phase 3
Vancouver, Washington, United States and 152 other locations
CLN-081-001 is a Phase 1/2, open label, multi-center study of CLN-081 in patients with non-small cell lung cancer...
Phase 1, Phase 2
Portland, Oregon, United States and 63 other locations
The primary purpose of this study is to evaluate the efficacy and safety of X-396 (ensartinib) vs. crizotinib in patients with ALK-positive non...
Phase 3
Portland, Oregon, United States and 71 other locations
Clinical trials
Research sites
Resources
Legal